One of the notable breakthroughs was the first-in-human PET imaging with a 68Ga-labeled PSMA-targeting agent, [68Ga]Ga-PSMA-11 ([68Ga]PSMA-HBED-CC or [68Ga]DKFZ-PSMA-11 in the literature), reported by the German Cancer Research Center and the University Hospital Heidelberg [44]. The gene discussed is FOLH1; the disease is cancer.